Fermentalg structures its transformation to support its ambitions

Fermentalg, a major player in bio-solutions based on aquatic microorganisms, continues its strategic transformation under the leadership of Pierre Josselin. With a large patent portfolio and partnerships with industrial leaders such as HuvePharma, Givaudan and Suez, the company stands out in sustainable development and global health.

The Libourne-based company is restructuring its sales organisation to target priority markets, particularly food supplements, infant nutrition and cosmetics, in order to achieve significant market shares. It is banking on a renewed customer approach and geographical expansion, particularly in the United States and China.

Fermentalg aims to increase its turnover sixfold by 2026, reaching more than €25 million. This development is based on the industrialization of new products and the optimization of production costs, with the objective of a balanced EBITDA in 2026.